全文获取类型
收费全文 | 3669篇 |
免费 | 250篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 90篇 |
妇产科学 | 83篇 |
基础医学 | 510篇 |
口腔科学 | 54篇 |
临床医学 | 434篇 |
内科学 | 977篇 |
皮肤病学 | 60篇 |
神经病学 | 403篇 |
特种医学 | 61篇 |
外科学 | 364篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 337篇 |
眼科学 | 94篇 |
药学 | 198篇 |
中国医学 | 8篇 |
肿瘤学 | 214篇 |
出版年
2023年 | 15篇 |
2022年 | 49篇 |
2021年 | 78篇 |
2020年 | 48篇 |
2019年 | 81篇 |
2018年 | 100篇 |
2017年 | 68篇 |
2016年 | 78篇 |
2015年 | 108篇 |
2014年 | 144篇 |
2013年 | 160篇 |
2012年 | 248篇 |
2011年 | 236篇 |
2010年 | 130篇 |
2009年 | 110篇 |
2008年 | 209篇 |
2007年 | 224篇 |
2006年 | 212篇 |
2005年 | 212篇 |
2004年 | 244篇 |
2003年 | 223篇 |
2002年 | 218篇 |
2001年 | 63篇 |
2000年 | 72篇 |
1999年 | 71篇 |
1998年 | 44篇 |
1997年 | 42篇 |
1996年 | 24篇 |
1995年 | 32篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 31篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 24篇 |
1988年 | 26篇 |
1987年 | 21篇 |
1986年 | 21篇 |
1985年 | 22篇 |
1984年 | 22篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1975年 | 9篇 |
1974年 | 9篇 |
1972年 | 6篇 |
排序方式: 共有3926条查询结果,搜索用时 78 毫秒
1.
2.
3.
4.
F. Giovanardi F. Nudo Q. Lai M. Garofalo A. Consolo E. Choppin De Janvry G.A. Arroyo Murillo P. Ursi D. Stabile F. Melandro P.B. Berloco R. Pretagostini L. Poli 《Transplantation proceedings》2019,51(1):128-131
Background
Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.Methods
During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.Results
No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.Conclusions
The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach. 相似文献5.
6.
7.
8.
9.
Dino Donataccio Francine Roggen Chantal De Reyck Catherine Verbaandert Monique Bodeus Jan Lerut 《Transplant international》2006,19(1):38-43
The use of livers from anti-hepatitis B core (HBc) positive donors can alleviate donor shortage. Nineteen of 367 (6%) adults receiving anti-HBc positive allografts [three were hepatitis B antigen (HBsAg) negative, hepatitis B antibody (HBsAb) positive; four were HBsAg positive and 12 were not exposed to hepatitis B viral (HBV) infection] were retrospectively reviewed. In HBsAg negative recipients, immunoprophylaxis (IP) was guided by viral serology and immunohistochemistry (IH) of day 0 and day 7 liver biopsies. If IH was negative, IP was stopped. None of three HBsAg negative, HBsAb positive recipients infected; one (replicating) of four HBsAg positive recipients reinfected and seven of eight (87.5%) HBsAg, HBsAb negative recipients, who did not receive long-term IP, infected after a median time of 2 years (range 1-5); one patient died of liver failure. Four HBsAg, HBsAb negative recipients, receiving life-long IP, remained infection free. Anti-HBc positive donor livers must be directed selectively first to HBsAg positive recipients, next to recipients having HBV antibodies and finally to HBV-naive recipients. Identification of both donor and recipient risk factors for HBV infection before transplantation allows indiscriminate use of antiviral prophylaxis. The necessity for IP therapy should be guided by HBV-DNA testing of donor liver tissue and serum. IH of early liver biopsies is an unreliable marker for predicting antiviral treatment requirements. 相似文献
10.